NASDAQ: BMRN - BioMarin Pharmaceutical

Yield per half year: -9.74%
Dividend yield: 0.00%
Sector: Healthcare

Share chart BioMarin Pharmaceutical

Extended chart Simple chart
Financial Markets by TradingView

About BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.  — американская биотехнологическая компания со штаб-квартирой в Сан-Рафаэле, Калифорния . У него есть офисы и помещения в США , Южной Америке , Азии и Европе . Основным направлением деятельности и исследованиями BioMarin является заместительная терапия ферментами (ФЗТ).

more details
 BioMarin была первой компанией, которая предоставила терапевтические средства для лечения мукополисахаридоза типа I (MPS I), производя ларонидазу ( Aldurazyme , коммерциализируется Genzyme Corporation). BioMarin также была первой компанией, которая начала предлагать препараты для лечения фенилкетонурии.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 1999-07-23
ISIN US09061G1013
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.biomarin.com
Цена ао 71.53
Change price per day: +0.8926% (62.74)
Change price per week: +6.98% (59.17)
Change price per month: -11.44% (71.48)
Change price per 3 month: +2.54% (61.73)
Change price per half year: -9.74% (70.13)
Change price per year: -21.76% (80.91)
Change price per 3 year: -20.6% (79.72)
Change price per 5 year: -26.83% (86.51)
Change price per 10 year: -16.28% (75.61)
Change price per year to date: -3.7% (65.73)
All parameters

Underestimation

Title Value Grade
P/S 4.51 3
P/BV 3.72 5
P/E 30.16 5
EV/EBITDA 71.81 1
Total: 5.25

Efficiency

Title Value Grade
ROA, % 2.45 1
ROE, % 3.39 1
Total: 2.17

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.2271

Debt

Title Value Grade
Debt/EBITDA 2.26 6
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 53.44 7
Yield Ebitda, % -8307.02 0
Yield EPS, % -51.56 0
Total: 1.4
More

Institutions Volume Share, %
PRIMECAP Management Company 18414374 9.76
Vanguard Group Inc 18050062 9.57
Blackrock Inc. 14681644 7.78
Dodge & Cox Inc 13994063 7.42
Capital Research Global Investors 10774641 5.71
State Street Corporation 6730515 3.57
Ameriprise Financial, Inc. 5419366 2.87
Barclays PLC 5288893 2.8
Viking Global Investors, L.P. 4889454 2.59
Avoro Capital Advisors LLC 4300000 2.28

ETFShare, %Profitability for 1 year, %Dividends, %
VictoryShares Nasdaq Next 50 ETF 1.38305 25.65 0.64752
iShares Evolved U.S. Innovative Healthcare ETF 1.35 0.000586 2.79
Future Tech ETF 1.30612 426.34 0.8416
Principal Healthcare Innovators ETF 1.30612 618.5 0.8416
IQ Engender Equality ETF 1.03522 30.64 1.74017
GraniteShares XOUT U.S. Large Cap ETF 0.86381 -4.52 0.28223
Syntax Stratified MidCap ETF 0.34133 17.66 1.56212
iShares Morningstar Mid-Cap Growth ETF 0.24673 458.38 0.94237
iShares Morningstar Mid-Cap ETF 0.12333 260.95 1.7458
iShares Morningstar Large-Cap Growth ETF 0.05463 291.4 0.5823
iShares Morningstar Large-Cap ETF 0.0266 257.57 1.41244
Columbia U.S. ESG Equity Income ETF 0.02348 -99.18 1.44131
0.67190.281.24



Head Job title Payment Year of birth
Mr. Brian R. Mueller CFO & Executive VP 1.15M 1974 (51 year)
Mr. George Eric Davis Executive VP, Chief Legal Officer, General Counsel & Secretary 1.23M 1971 (54 years)
Ms. Erin Burkhart Group VP & Chief Accounting Officer N/A 1979 (46 years)
Mr. Alexander Hardy President, CEO & Director N/A 1969 (56 years)
Dr. C. Greg Guyer Ph.D. Executive VP & CTO 1962 (63 years)
Dr. Kevin Eggan Ph.D. Chief Scientific Officer & Senior VP of Research and Early Development
Traci McCarty Group Vice President of Investor Relations
Ms. Humaira Serajuddin Senior VP & Chief Marketing Officer
Ms. Amy Wireman Executive VP & Chief People Officer

Address: United States, San Rafael, 770 Lindaro Street - open in Google maps, open in Yandex maps
Website: http://www.biomarin.com